These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23949089)

  • 1. Preoperative estimated glomerular filtration rate as a significant predictor of long-term outcomes after coronary artery bypass grafting in Japanese patients.
    Domoto S; Tagusari O; Nakamura Y; Takai H; Seike Y; Ito Y; Shibuya Y; Shikata F
    Gen Thorac Cardiovasc Surg; 2014 Feb; 62(2):95-102. PubMed ID: 23949089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of chronic kidney disease on early clinical outcomes after off-pump coronary artery bypass grafting.
    Li X; Zhang S; Xiao F
    J Cardiothorac Surg; 2020 Jul; 15(1):199. PubMed ID: 32727495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-pump bilateral skeletonized internal thoracic artery grafting in patients with chronic kidney disease.
    Kinoshita T; Asai T; Suzuki T
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):315-21.e3. PubMed ID: 26142149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents.
    Pan Y; Qiu Q; Chen F; Li X; Yu X; Luo Y; Li Q; He J; Gao Y; Zhang X; Ren X
    Coron Artery Dis; 2016 Nov; 27(7):535-42. PubMed ID: 27269882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of estimated glomerular filtration rate on the 15-year outcome after coronary artery bypass surgery.
    Kangasniemi OP; Mahar MA; Rasinaho E; Satomaa A; Tiozzo V; Lepojärvi M; Biancari F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):198-202. PubMed ID: 18068374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.
    Lima EG; Charytan DM; Hueb W; de Azevedo DFC; Garzillo CL; Favarato D; Linhares Filho JPP; Martins EB; Batista DV; Rezende PC; Hueb AC; Ramires JAF; Kalil Filho R
    Nephrol Dial Transplant; 2020 Aug; 35(8):1369-1376. PubMed ID: 30590726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of occult renal impairment on early and late outcomes following coronary artery bypass grafting.
    Marui A; Okabayashi H; Komiya T; Tanaka S; Furukawa Y; Kita T; Kimura T; Sakata R;
    Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):638-43. PubMed ID: 23793709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with chronic kidney disease and unprotected left main coronary artery disease.
    Kim DW; Om SY; Park MW; Park HW; Lee PH; Kang DY; Ahn JM; Lee CW; Park SW; Park SJ; Her SH; Park DW
    EuroIntervention; 2020 May; 16(1):27-35. PubMed ID: 31380780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An optimal strategy for coronary revascularization in patients with severe renal dysfunction.
    Komiya T; Ueno G; Kadota K; Mitsudo K; Okabayashi H; Nishiwaki N; Hanyu M; Kimura T; Tanaka S; Marui A; Sakata R;
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):293-300. PubMed ID: 25416698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary Artery Bypass Grafting in Patients with Chronic Kidney Disease: Chronic Kidney Disease Has an Independent Adverse Effect on the Long-Term Outcome of Coronary Artery Bypass Grafting.
    Endo D; Yamamoto T; Kajimoto K; Matsushita S; Dohi S; Shimada A; Yokoyama Y; Io H; Suzuki Y; Tabata M; Amano A
    Biomed Res Int; 2022; 2022():4994970. PubMed ID: 35528157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
    Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
    Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term cardiovascular outcomes in patients with chronic kidney disease undergoing coronary artery bypass graft surgery for acute coronary syndromes.
    Holzmann M; Jernberg T; Szummer K; Sartipy U
    J Am Heart Assoc; 2014 Mar; 3(2):e000707. PubMed ID: 24595192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b-5 chronic kidney disease.
    Lautamäki A; Kiviniemi T; Biancari F; Airaksinen J; Juvonen T; Gunn J
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):926-30. PubMed ID: 26142469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function and coronary bypass surgery in patients with ischemic heart failure.
    Doenst T; Haddad H; Stebbins A; Hill JA; Velazquez EJ; Lee KL; Rouleau JL; Sopko G; Farsky PS; Al-Khalidi HR;
    J Thorac Cardiovasc Surg; 2022 Feb; 163(2):663-672.e3. PubMed ID: 32386761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of s-cystatin C for mortality after coronary artery bypass surgery.
    Dardashti A; Nozohoor S; Algotsson L; Ederoth P; Bjursten H
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):139-46. PubMed ID: 27056756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Barbarawi M; Zayed Y; Hamid K; Kheiri B; Barbarawi O; Sundus S; Rashdan L; Alabdouh A; Chahine A; Bachuwa G; Alkotob ML
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1184-1189. PubMed ID: 30842042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial.
    Milojevic M; Head SJ; Mack MJ; Mohr FW; Morice MC; Dawkins KD; Holmes DR; Serruys PW; Kappetein AP
    EuroIntervention; 2018 May; 14(1):102-111. PubMed ID: 29155387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
    Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary Artery Bypass Surgery versus Percutaneous Coronary Intervention for Left Main Coronary Artery Disease with Chronic Kidney Disease.
    Lin TC; Lu TM; Huang FC; Hsu PF; Shih CC; Lin SJ; Hsu CP
    Int Heart J; 2018 Mar; 59(2):279-285. PubMed ID: 29563384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.
    Ashrith G; Lee VV; Elayda MA; Reul RM; Wilson JM
    Am J Cardiol; 2010 Aug; 106(3):348-53. PubMed ID: 20643244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.